SlideShare a Scribd company logo
1 of 10
Signalment:
2-year-old, male-entire, Springer spaniel
Clinical history:
Presented with a three-month history of worsening, intermittent, unilateral (right-sided) epistaxis and
occasional cough. Concurrently, poor coat quality, particularly caudally.
They were up to date with vaccinations, given Advantix (imidacloprid / permethrin) intermittently, and
given a supermarket wormer intermittently. No history of travel outside of southern Wales.
No improvement following treatment with antimicrobials or non-steroidal anti-inflammatory
medication.
Recent blood analysis revealed a strongly regenerative mild anaemia (haematocrit 35%) and a mild
thrombocytopenia. Serum biochemistry was unremarkable.
QUESTION 1: What are your problems?
> Go to next page for answers
Case example 2B
Physical examination:
Extremely bright and in good body condition. A small amount of clotted blood was visible at the entrance to the right nares.
Mucous membranes were pale pink and no petechiations were visible. Heart rate was increased (160/min) with slightly bounding pulses.
Rectal temperature was borderline increased (39.2°C).
QUESTION 1: What are your problems?
ANSWER:
• Major concerns
o 3-month history of intermittent, unilateral epistaxis that was progressive and had not responded to
antimicrobial / anti-inflammatory medication
• Minor concerns
o Strongly-regenerative mild anaemia
o Mild thrombocytopenia
o Pale mucous membranes
o Tachycardia on physical exam
o Occasional cough over the same time frame
o Poor coat
o Borderline hyperthermia
QUESTION 2: What are your differentials?
> Go to next page for answers
QUESTION 2: What are your differentials?
ANSWER:
• Epistaxis
o Structural disorder – infection (fungal rhinitis / aspergillosis); neoplasia; inflammation (chronic rhinitis); dental
disease; others
o Haematological disorder – coagulopathy (angiostrongylosis; rodenticide toxicity; haemophilia)
o Vascular disorder – hypertension
Notes: The major concern is a 3-month history of intermittent, unilateral epistaxis that was progressive and had not
responded to antimicrobial / anti-inflammatory medication
• It is chronic – ruling out trauma; this also makes rodenticide toxicity less likely, as they would have to be repeatedly
ingesting it!
• Coagulopathy due to hyperviscosity (hyperglobulinaemia-related) has been ruled out with the unremarkable serum
biochemistry
• It is unilateral and progressive – making a localised structural problem more likely
• It did not respond to empirical treatment – but most of the differentials would not have responded to this treatment
anyway
• The discharge was purely blood making most inflammatory conditions less likely – but due to its destructive nature
fungal rhinitis can do this
> Answer continued on next page
… continued… QUESTION 2: What are your differentials?
Whilst, we tend to focus on the major problems, considering the minor issues can sometimes raise the suspicions of differentials for the major
problem. It also highlights areas we might want to assess before proceeding to more invasive procedures.
• Strongly-regenerative mild anaemia
o Blood loss
o (very well compensated) immune-mediated haemolysis
• Mild thrombocytopenia
o Consumption – blood loss; disseminated intravascular coagulopathy
o Immune-mediated destruction
o Production issue
• Pale mucous membranes
o Anaemia – blood loss; red cell destruction
o Reduced peripheral perfusion – adrenaline response (stress); hypovolaemia (blood loss); reduced cardiac output
• Cough
o Post-nasal drip
o Disease somewhere else in the respiratory tract e.g. tracheobronchial (infectious; inflammatory), pulmonary (leading to fluid in the
airways e.g. angiostrongylosis)
• Poor coat
o Systemic disease – chronic inflammatory disease; poor nutrition; endocrinopathy
• Hyperthermia
o Physiological – stress of travel
o Pathological – systemic inflammation
> Answer continued on next page
… continued… QUESTION 2: What are your differentials?
Notes: The strongly regenerative mild anaemia is likely related to chronic blood loss from the epistaxis. The regenerative response
rules out non-regenerative causes of anaemia and with immune-mediated haemolysis the anaemia is typically severe. But would you
expect an otherwise fit young dog to be pale and have tachycardia with an haematocrit of 35%?
Chronic haemorrhage is a potent stimulator of platelet production, as compared to following acute haemorrhage consumption of
platelets may reduce their numbers. Therefore, the presence of mild thrombocytopenia is suspicious, but could potentially be
explained by an acute on chronic episode. In immune-mediated conditions a lower value (often absolute thrombocytopenia) might be
expected. Spontaneous haemorrhage is not seen until platelets drop below 40-50 x109/L and, even then, large bleeds are not
expected but petechiation would.
The pale mucous membranes and tachycardia could be due to progression of the anaemia, hypovolaemia or another cause of
adrenaline release. Blood loss via another route was not reported, but cannot be ruled out.
The occasional cough could be i) as a result of nasal disease (post-nasal drip), ii) the same disease process as in nose now in the lungs
(infection; inflammation – eosinophilic broncho-pneumopathy; neoplasia), iii) something unrelated.
The poor coat could be a reflection of systemic disease leading to metabolic compromise, or be a ‘red herring’.
The hyperthermia could reflect a systemic inflammatory response or the stress of travel.
QUESTION 3: What do you want to do next?
> Go to next page for answers
QUESTION 3: What do you want to do next?
ANSWER
• Haematology (repeat) – check for progression of the anaemia (e.g. severity; degree of regenerative response);
check platelets
• Clotting screen – check for coagulopathy (before making any further holes in the patient!)
• Angiostrongylus vasorum serology – check for angiostrongylosis (can cause bleeding disorder in the absence of
detectable changes on haematology / clotting screen)
• Faecal analysis – check for angiostrongylosis (sensitivity of the AngioDetectTM is not 100%)
• Diagnostic imaging – CT head and thorax
• Endoscopy – rhinoscopy with biopsy; bronchoscopy with bronchoalveolar lavage
Estimate to get an answer (i.e. does not include treatment) £4000 (£3000-3500 if do not perform CT of thorax or
bronchoscopy/BAL). As serum biochemistry was recently performed, and was unremarkable, it was not repeated.
> Go to next page for test results
Investigation
Blood analysis was performed, whilst an IV catheter was placed
and blood pressure measured.
Blood analysis
Haematology and clotting screen
Infectious disease screening
Lateral flow for Angiostrongylus vasorum
antigen in serum (AngioDetectTM) was
strongly positive
Faecal analysis
Angiostrongylus spp. larvae were noted on
faecal examination
Additional tests
Blood pressure was acceptable.
An episode of marked epistaxis started
shortly after presentation.
QUESTION 4: What do you think is
going on? What do you want to do
next (i.e. have these results changed
your investigation plan)?
> Go to next page for answers
QUESTION 4: What do you think is going on? What do you want to do next (i.e. have these results changed your
investigation plan)?
ANSWER:
Conclusions, Treatment & Outcome
Preliminary conclusions
• Severe coagulopathy—most likely consumptive (cf. inherited clotting factor deficiency, as haemophilia should only affect
the PTT pathway, unless a combination)
• Mild anaemia, but evidence of regenerative response (a reticulocyte count would be required to confirm this). No
evidence of spherocytes to suggest an immune-mediated haemolytic process
• A moderate-severe thrombocytopenia—most likely consumptive (cf. immune-mediated, as these are usually extreme).
Insufficient to cause haemorrhage in its own right
• Mild mature neutrophilia and monocytosis—consistent with chronic inflammation (non-specific)
• Angiostrongylus vasorum infection
> Answer continued on next page
Most likely scenario
Angiostrongylus vasorum infection  chronic DIC (consumptive thrombocytopenia ; coagulopathy )  haemorrhage (epistaxis ;
regenerative anaemia )
Angiostrongylosis could also account for the cough—either as a result of post-nasal drip or due to primary pulmonary disease
But
Could not rule out: structural nasal disease; concurrent pulmonary disease; rodenticide toxicity
Plus, the degree of anaemia does not account for the tachycardia
Initial treatment
• Fresh frozen plasma—two units were administered (based upon size) immediately; then, as clotting screen was still abnormal and
epistaxis persisted, a subsequent third unit
• Vitamin K
• Advocate (imidacloprid / moxidectin)
• Fenbendazole (50mg/kg orally once daily) for 10 days
As they were actively bleeding a plasma transfusion was indicated and the calculated initial treatment volume was given; however, as
clinical signs persisted (likely due to ongoing losses and consumption) this was continued ‘to effect’ (i.e. normalisation of clotting times).
Although transfusion of packed red cells had been considered, it was not deemed necessary as his heart rate improved following this colloid
support. Ultimately, the haematocrit then dropped to 23%.
Were only whole blood available for transfusion this could have been considered, but a greater number of units may have been required.
The vitamin K would have been necessary if the coagulopathy is rodenticide related (in addition to the plasma); however, even if the
coagulopathy was not rodenticide related it is not going to be harmful and could be of benefit.
> Answer continued on next page
Outcome
Rectal temperature normalised during hospitalisation, and was subsequently ignored. The heart rate normalised
during hospitalisation / following plasma transfusion. The tachycardia could then have been situational or due to
blood-loss hypovolaemia. The epistaxis stopped 24 hours after starting the plasma transfusions. No further
investigation was performed at that time.
The haematocrit and clotting times normalised over the following two weeks. It was therefore assumed that both had
solely been due to the angiostrongylosis. Further investigation was deferred, pending recurrence of clinical signs—
which did not happen. Both the epistaxis and the cough were therefore attributed to angiostrongylosis. With time his
coat quality improved. Monthly Advocate was continued for him (and all other dogs in the household).

More Related Content

What's hot

Thrombocytopenia
ThrombocytopeniaThrombocytopenia
ThrombocytopeniaDilmo Yeldo
 
Cases in cardiology part one PART FOUR 2016--
Cases in cardiology part one PART FOUR 2016--Cases in cardiology part one PART FOUR 2016--
Cases in cardiology part one PART FOUR 2016--cardilogy
 
Immune thrombocytopenia purpura (itp)
Immune thrombocytopenia purpura (itp)Immune thrombocytopenia purpura (itp)
Immune thrombocytopenia purpura (itp)Fikri Abdullah Zawawi
 
Hematology - Oncology emergencies
Hematology - Oncology emergenciesHematology - Oncology emergencies
Hematology - Oncology emergenciesAkshat Jain M.D.
 
approach to child with purpura
 approach to child with purpura approach to child with purpura
approach to child with purpuraMuhammad Jawad
 
Idiopathic thrombocytopenic purpura
Idiopathic thrombocytopenic purpuraIdiopathic thrombocytopenic purpura
Idiopathic thrombocytopenic purpuraAtheer Al-zubedi
 
ITP by dr. Mohib Ali
ITP by dr. Mohib AliITP by dr. Mohib Ali
ITP by dr. Mohib AliMohib Ali
 
13038030 surgical-infections
13038030 surgical-infections13038030 surgical-infections
13038030 surgical-infectionsTsega Tilahun
 
CARDIAC PATHOLOGY (MCQ QUESTIONS & ANSWERS)
CARDIAC PATHOLOGY (MCQ QUESTIONS & ANSWERS)CARDIAC PATHOLOGY (MCQ QUESTIONS & ANSWERS)
CARDIAC PATHOLOGY (MCQ QUESTIONS & ANSWERS)Suraj Dhara
 
Cases in cardiology --LMB-- part one -- PART TWO-- MAGDI SASI 2016
Cases in cardiology --LMB-- part one -- PART TWO-- MAGDI SASI 2016Cases in cardiology --LMB-- part one -- PART TWO-- MAGDI SASI 2016
Cases in cardiology --LMB-- part one -- PART TWO-- MAGDI SASI 2016cardilogy
 
Immune Thrombocytopenic
Immune ThrombocytopenicImmune Thrombocytopenic
Immune ThrombocytopenicEneutron
 

What's hot (20)

Hematologic emergency
Hematologic emergencyHematologic emergency
Hematologic emergency
 
Shock in children
Shock in childrenShock in children
Shock in children
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
 
Thrombocytopenic purpura
Thrombocytopenic purpuraThrombocytopenic purpura
Thrombocytopenic purpura
 
Cases in cardiology part one PART FOUR 2016--
Cases in cardiology part one PART FOUR 2016--Cases in cardiology part one PART FOUR 2016--
Cases in cardiology part one PART FOUR 2016--
 
Immune thrombocytopenia purpura (itp)
Immune thrombocytopenia purpura (itp)Immune thrombocytopenia purpura (itp)
Immune thrombocytopenia purpura (itp)
 
Hematology - Oncology emergencies
Hematology - Oncology emergenciesHematology - Oncology emergencies
Hematology - Oncology emergencies
 
Itp
ItpItp
Itp
 
approach to child with purpura
 approach to child with purpura approach to child with purpura
approach to child with purpura
 
Shock
ShockShock
Shock
 
Idiopathic thrombocytopenic purpura
Idiopathic thrombocytopenic purpuraIdiopathic thrombocytopenic purpura
Idiopathic thrombocytopenic purpura
 
CME: Management of Severe Sepsis & Septic Shock
CME: Management of Severe Sepsis & Septic ShockCME: Management of Severe Sepsis & Septic Shock
CME: Management of Severe Sepsis & Septic Shock
 
ITP by dr. Mohib Ali
ITP by dr. Mohib AliITP by dr. Mohib Ali
ITP by dr. Mohib Ali
 
Paediatric septic-shock
Paediatric septic-shockPaediatric septic-shock
Paediatric septic-shock
 
13038030 surgical-infections
13038030 surgical-infections13038030 surgical-infections
13038030 surgical-infections
 
CARDIAC PATHOLOGY (MCQ QUESTIONS & ANSWERS)
CARDIAC PATHOLOGY (MCQ QUESTIONS & ANSWERS)CARDIAC PATHOLOGY (MCQ QUESTIONS & ANSWERS)
CARDIAC PATHOLOGY (MCQ QUESTIONS & ANSWERS)
 
Itp
ItpItp
Itp
 
Cases in cardiology --LMB-- part one -- PART TWO-- MAGDI SASI 2016
Cases in cardiology --LMB-- part one -- PART TWO-- MAGDI SASI 2016Cases in cardiology --LMB-- part one -- PART TWO-- MAGDI SASI 2016
Cases in cardiology --LMB-- part one -- PART TWO-- MAGDI SASI 2016
 
Idiopathic Thrombocytopenic Purpura
Idiopathic Thrombocytopenic PurpuraIdiopathic Thrombocytopenic Purpura
Idiopathic Thrombocytopenic Purpura
 
Immune Thrombocytopenic
Immune ThrombocytopenicImmune Thrombocytopenic
Immune Thrombocytopenic
 

Similar to Springer Spaniel with Epistaxis and Coagulopathy

Mod 1 case 2022
Mod 1 case 2022Mod 1 case 2022
Mod 1 case 2022vetindex4
 
Mod 5 case 2022
Mod 5 case 2022Mod 5 case 2022
Mod 5 case 2022vetindex4
 
Mod 6 case 2022
Mod 6 case 2022Mod 6 case 2022
Mod 6 case 2022vetindex4
 
Takaysu Glomerulonephritis
Takaysu GlomerulonephritisTakaysu Glomerulonephritis
Takaysu GlomerulonephritisBeka Aberra
 
SEPTIC SHOCK-DR.LANDO ELVIS O.pptx
SEPTIC SHOCK-DR.LANDO ELVIS O.pptxSEPTIC SHOCK-DR.LANDO ELVIS O.pptx
SEPTIC SHOCK-DR.LANDO ELVIS O.pptxLando Elvis
 
FN, sepsis and shock
FN, sepsis and shockFN, sepsis and shock
FN, sepsis and shockderosaMSKCC
 
Approach to Sepsis & Septic Shock in Emergency Medicine.
Approach to Sepsis & Septic Shock in Emergency Medicine.Approach to Sepsis & Septic Shock in Emergency Medicine.
Approach to Sepsis & Septic Shock in Emergency Medicine.AngelGovekar
 
Hemorrhagic shock Seminar
Hemorrhagic shock SeminarHemorrhagic shock Seminar
Hemorrhagic shock Seminarpradeepmk8
 
Shock: types of shock, treatment - General Medicine - ATOT
Shock: types of shock, treatment - General Medicine - ATOTShock: types of shock, treatment - General Medicine - ATOT
Shock: types of shock, treatment - General Medicine - ATOTDr. Salman Ansari
 
Shock - the life threatening condition
Shock - the life threatening conditionShock - the life threatening condition
Shock - the life threatening conditionNehaNupur8
 
Nephritis2008.
Nephritis2008.Nephritis2008.
Nephritis2008.Deep Deep
 

Similar to Springer Spaniel with Epistaxis and Coagulopathy (20)

Mod 1 case 2022
Mod 1 case 2022Mod 1 case 2022
Mod 1 case 2022
 
Mod 5 case 2022
Mod 5 case 2022Mod 5 case 2022
Mod 5 case 2022
 
Mod 6 case 2022
Mod 6 case 2022Mod 6 case 2022
Mod 6 case 2022
 
Septic shock.pptx
Septic shock.pptxSeptic shock.pptx
Septic shock.pptx
 
Takaysu Glomerulonephritis
Takaysu GlomerulonephritisTakaysu Glomerulonephritis
Takaysu Glomerulonephritis
 
Shock
Shock  Shock
Shock
 
Sepsis nuts&bolts
Sepsis nuts&boltsSepsis nuts&bolts
Sepsis nuts&bolts
 
SEPTIC SHOCK-DR.LANDO ELVIS O.pptx
SEPTIC SHOCK-DR.LANDO ELVIS O.pptxSEPTIC SHOCK-DR.LANDO ELVIS O.pptx
SEPTIC SHOCK-DR.LANDO ELVIS O.pptx
 
Sepsis
SepsisSepsis
Sepsis
 
FN, sepsis and shock
FN, sepsis and shockFN, sepsis and shock
FN, sepsis and shock
 
Approach to Sepsis & Septic Shock in Emergency Medicine.
Approach to Sepsis & Septic Shock in Emergency Medicine.Approach to Sepsis & Septic Shock in Emergency Medicine.
Approach to Sepsis & Septic Shock in Emergency Medicine.
 
Sepsis
SepsisSepsis
Sepsis
 
Management of shock
Management of shockManagement of shock
Management of shock
 
SHOCK Assignment.pptx
SHOCK Assignment.pptxSHOCK Assignment.pptx
SHOCK Assignment.pptx
 
Hemorrhagic shock Seminar
Hemorrhagic shock SeminarHemorrhagic shock Seminar
Hemorrhagic shock Seminar
 
Shock: types of shock, treatment - General Medicine - ATOT
Shock: types of shock, treatment - General Medicine - ATOTShock: types of shock, treatment - General Medicine - ATOT
Shock: types of shock, treatment - General Medicine - ATOT
 
Shock - the life threatening condition
Shock - the life threatening conditionShock - the life threatening condition
Shock - the life threatening condition
 
Nephritis2008.
Nephritis2008.Nephritis2008.
Nephritis2008.
 
Autoimmune hemolytic anemia
Autoimmune hemolytic anemiaAutoimmune hemolytic anemia
Autoimmune hemolytic anemia
 
Dr.cazaam
Dr.cazaamDr.cazaam
Dr.cazaam
 

Recently uploaded

Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 

Recently uploaded (20)

Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 

Springer Spaniel with Epistaxis and Coagulopathy

  • 1. Signalment: 2-year-old, male-entire, Springer spaniel Clinical history: Presented with a three-month history of worsening, intermittent, unilateral (right-sided) epistaxis and occasional cough. Concurrently, poor coat quality, particularly caudally. They were up to date with vaccinations, given Advantix (imidacloprid / permethrin) intermittently, and given a supermarket wormer intermittently. No history of travel outside of southern Wales. No improvement following treatment with antimicrobials or non-steroidal anti-inflammatory medication. Recent blood analysis revealed a strongly regenerative mild anaemia (haematocrit 35%) and a mild thrombocytopenia. Serum biochemistry was unremarkable. QUESTION 1: What are your problems? > Go to next page for answers Case example 2B Physical examination: Extremely bright and in good body condition. A small amount of clotted blood was visible at the entrance to the right nares. Mucous membranes were pale pink and no petechiations were visible. Heart rate was increased (160/min) with slightly bounding pulses. Rectal temperature was borderline increased (39.2°C).
  • 2. QUESTION 1: What are your problems? ANSWER: • Major concerns o 3-month history of intermittent, unilateral epistaxis that was progressive and had not responded to antimicrobial / anti-inflammatory medication • Minor concerns o Strongly-regenerative mild anaemia o Mild thrombocytopenia o Pale mucous membranes o Tachycardia on physical exam o Occasional cough over the same time frame o Poor coat o Borderline hyperthermia QUESTION 2: What are your differentials? > Go to next page for answers
  • 3. QUESTION 2: What are your differentials? ANSWER: • Epistaxis o Structural disorder – infection (fungal rhinitis / aspergillosis); neoplasia; inflammation (chronic rhinitis); dental disease; others o Haematological disorder – coagulopathy (angiostrongylosis; rodenticide toxicity; haemophilia) o Vascular disorder – hypertension Notes: The major concern is a 3-month history of intermittent, unilateral epistaxis that was progressive and had not responded to antimicrobial / anti-inflammatory medication • It is chronic – ruling out trauma; this also makes rodenticide toxicity less likely, as they would have to be repeatedly ingesting it! • Coagulopathy due to hyperviscosity (hyperglobulinaemia-related) has been ruled out with the unremarkable serum biochemistry • It is unilateral and progressive – making a localised structural problem more likely • It did not respond to empirical treatment – but most of the differentials would not have responded to this treatment anyway • The discharge was purely blood making most inflammatory conditions less likely – but due to its destructive nature fungal rhinitis can do this > Answer continued on next page
  • 4. … continued… QUESTION 2: What are your differentials? Whilst, we tend to focus on the major problems, considering the minor issues can sometimes raise the suspicions of differentials for the major problem. It also highlights areas we might want to assess before proceeding to more invasive procedures. • Strongly-regenerative mild anaemia o Blood loss o (very well compensated) immune-mediated haemolysis • Mild thrombocytopenia o Consumption – blood loss; disseminated intravascular coagulopathy o Immune-mediated destruction o Production issue • Pale mucous membranes o Anaemia – blood loss; red cell destruction o Reduced peripheral perfusion – adrenaline response (stress); hypovolaemia (blood loss); reduced cardiac output • Cough o Post-nasal drip o Disease somewhere else in the respiratory tract e.g. tracheobronchial (infectious; inflammatory), pulmonary (leading to fluid in the airways e.g. angiostrongylosis) • Poor coat o Systemic disease – chronic inflammatory disease; poor nutrition; endocrinopathy • Hyperthermia o Physiological – stress of travel o Pathological – systemic inflammation > Answer continued on next page
  • 5. … continued… QUESTION 2: What are your differentials? Notes: The strongly regenerative mild anaemia is likely related to chronic blood loss from the epistaxis. The regenerative response rules out non-regenerative causes of anaemia and with immune-mediated haemolysis the anaemia is typically severe. But would you expect an otherwise fit young dog to be pale and have tachycardia with an haematocrit of 35%? Chronic haemorrhage is a potent stimulator of platelet production, as compared to following acute haemorrhage consumption of platelets may reduce their numbers. Therefore, the presence of mild thrombocytopenia is suspicious, but could potentially be explained by an acute on chronic episode. In immune-mediated conditions a lower value (often absolute thrombocytopenia) might be expected. Spontaneous haemorrhage is not seen until platelets drop below 40-50 x109/L and, even then, large bleeds are not expected but petechiation would. The pale mucous membranes and tachycardia could be due to progression of the anaemia, hypovolaemia or another cause of adrenaline release. Blood loss via another route was not reported, but cannot be ruled out. The occasional cough could be i) as a result of nasal disease (post-nasal drip), ii) the same disease process as in nose now in the lungs (infection; inflammation – eosinophilic broncho-pneumopathy; neoplasia), iii) something unrelated. The poor coat could be a reflection of systemic disease leading to metabolic compromise, or be a ‘red herring’. The hyperthermia could reflect a systemic inflammatory response or the stress of travel. QUESTION 3: What do you want to do next? > Go to next page for answers
  • 6. QUESTION 3: What do you want to do next? ANSWER • Haematology (repeat) – check for progression of the anaemia (e.g. severity; degree of regenerative response); check platelets • Clotting screen – check for coagulopathy (before making any further holes in the patient!) • Angiostrongylus vasorum serology – check for angiostrongylosis (can cause bleeding disorder in the absence of detectable changes on haematology / clotting screen) • Faecal analysis – check for angiostrongylosis (sensitivity of the AngioDetectTM is not 100%) • Diagnostic imaging – CT head and thorax • Endoscopy – rhinoscopy with biopsy; bronchoscopy with bronchoalveolar lavage Estimate to get an answer (i.e. does not include treatment) £4000 (£3000-3500 if do not perform CT of thorax or bronchoscopy/BAL). As serum biochemistry was recently performed, and was unremarkable, it was not repeated. > Go to next page for test results
  • 7. Investigation Blood analysis was performed, whilst an IV catheter was placed and blood pressure measured. Blood analysis Haematology and clotting screen Infectious disease screening Lateral flow for Angiostrongylus vasorum antigen in serum (AngioDetectTM) was strongly positive Faecal analysis Angiostrongylus spp. larvae were noted on faecal examination Additional tests Blood pressure was acceptable. An episode of marked epistaxis started shortly after presentation. QUESTION 4: What do you think is going on? What do you want to do next (i.e. have these results changed your investigation plan)? > Go to next page for answers
  • 8. QUESTION 4: What do you think is going on? What do you want to do next (i.e. have these results changed your investigation plan)? ANSWER: Conclusions, Treatment & Outcome Preliminary conclusions • Severe coagulopathy—most likely consumptive (cf. inherited clotting factor deficiency, as haemophilia should only affect the PTT pathway, unless a combination) • Mild anaemia, but evidence of regenerative response (a reticulocyte count would be required to confirm this). No evidence of spherocytes to suggest an immune-mediated haemolytic process • A moderate-severe thrombocytopenia—most likely consumptive (cf. immune-mediated, as these are usually extreme). Insufficient to cause haemorrhage in its own right • Mild mature neutrophilia and monocytosis—consistent with chronic inflammation (non-specific) • Angiostrongylus vasorum infection > Answer continued on next page
  • 9. Most likely scenario Angiostrongylus vasorum infection  chronic DIC (consumptive thrombocytopenia ; coagulopathy )  haemorrhage (epistaxis ; regenerative anaemia ) Angiostrongylosis could also account for the cough—either as a result of post-nasal drip or due to primary pulmonary disease But Could not rule out: structural nasal disease; concurrent pulmonary disease; rodenticide toxicity Plus, the degree of anaemia does not account for the tachycardia Initial treatment • Fresh frozen plasma—two units were administered (based upon size) immediately; then, as clotting screen was still abnormal and epistaxis persisted, a subsequent third unit • Vitamin K • Advocate (imidacloprid / moxidectin) • Fenbendazole (50mg/kg orally once daily) for 10 days As they were actively bleeding a plasma transfusion was indicated and the calculated initial treatment volume was given; however, as clinical signs persisted (likely due to ongoing losses and consumption) this was continued ‘to effect’ (i.e. normalisation of clotting times). Although transfusion of packed red cells had been considered, it was not deemed necessary as his heart rate improved following this colloid support. Ultimately, the haematocrit then dropped to 23%. Were only whole blood available for transfusion this could have been considered, but a greater number of units may have been required. The vitamin K would have been necessary if the coagulopathy is rodenticide related (in addition to the plasma); however, even if the coagulopathy was not rodenticide related it is not going to be harmful and could be of benefit. > Answer continued on next page
  • 10. Outcome Rectal temperature normalised during hospitalisation, and was subsequently ignored. The heart rate normalised during hospitalisation / following plasma transfusion. The tachycardia could then have been situational or due to blood-loss hypovolaemia. The epistaxis stopped 24 hours after starting the plasma transfusions. No further investigation was performed at that time. The haematocrit and clotting times normalised over the following two weeks. It was therefore assumed that both had solely been due to the angiostrongylosis. Further investigation was deferred, pending recurrence of clinical signs— which did not happen. Both the epistaxis and the cough were therefore attributed to angiostrongylosis. With time his coat quality improved. Monthly Advocate was continued for him (and all other dogs in the household).